Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001609805-25-000006
Filing Date
2025-09-16
Accepted
2025-09-16 16:15:05
Documents
1
Period of Report
2025-09-12

Document Format Files

Seq Description Document Type Size
1 form4-09162025_040901.html 4  
1 form4-09162025_040901.xml 4 9709
  Complete submission text file 0001609805-25-000006.txt   11205
Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Reporting) CIK: 0001609805 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42831 | Film No.: 251317489

Mailing Address 575 MADISON AVENUE NEW YORK NY 10022
Business Address 575 MADISON AVENUE NEW YORK NY 10022 917-450-6581
LB PHARMACEUTICALS INC (Issuer) CIK: 0001691082 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)